Renaissance Technologies
TENX icon

Renaissance Technologies’s Tenax Therapeutics TENX Stock Holding History

Renaissance Technologies’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.44M Buy
152,600
+27,021
+22% +$366K ﹤0.01% 1793
2025
Q4 		$1.53M Buy
125,579
+68,979
+122% +$600K ﹤0.01% 2035
2025
Q3 		$431K Buy
+56,600
New +$346K ﹤0.01% 2857
2024
Q1 		– Sell
-4,252
Closed -$93K – 4073
2023
Q4 		$93K Buy
+4,252
New +$102K ﹤0.01% 3317
2023
Q1 		– Sell
-40
Closed -$7K – 4399
2022
Q4 		$7K Sell
40
-49
-55% -$10.8K ﹤0.01% 4052
2022
Q3 		$24K Buy
89
+48
+117% +$19.3K ﹤0.01% 3876
2022
Q2 		$20K Sell
41
-1
-2% -$1K ﹤0.01% 4121
2022
Q1 		$55K Sell
42
-8
-16% -$8.91K ﹤0.01% 3898
2021
Q4 		$84K Sell
50
-14
-22% -$31.5K ﹤0.01% 3711
2021
Q3 		$182K Sell
64
-56
-47% -$147K ﹤0.01% 3224
2021
Q2 		$400K Sell
120
-347
-74% -$1.1M ﹤0.01% 3050
2021
Q1 		$1.42M Buy
467
+200
+75% +$714K ﹤0.01% 2428
2020
Q4 		$794K Sell
267
-63
-19% -$116K ﹤0.01% 2618
2020
Q3 		$812K Sell
330
-116
-26% -$248K ﹤0.01% 2615
2020
Q2 		$646K Buy
446
+83
+23% +$122K ﹤0.01% 2772
2020
Q1 		$332K Buy
363
+83
+30% +$146K ﹤0.01% 2935
2019
Q4 		$632K Buy
280
+24
+9% +$46.7K ﹤0.01% 2813
2019
Q3 		$491K Buy
256
+31
+14% +$64.4K ﹤0.01% 2876
2019
Q2 		$496K Buy
225
+74
+49% +$179K ﹤0.01% 3003
2019
Q1 		$489K Buy
151
+48
+47% +$109K ﹤0.01% 2926
2018
Q4 		$199K Buy
103
+48
+87% +$264K ﹤0.01% 3137
2018
Q3 		$461K Buy
55
+3
+6% +$28.3K ﹤0.01% 2874
2018
Q2 		$526K Buy
52
+16
+44% +$162K ﹤0.01% 2816
2018
Q1 		$313K Buy
36
+33
+1,100% +$380K ﹤0.01% 3065
2017
Q4 		$51K Buy
+3
New +$40.8K ﹤0.01% 3260
2016
Q4 		– Sell
-1
Closed -$58K – 3436
2016
Q3 		$58K Buy
+1
New +$78.9K ﹤0.01% 3243

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies's TENX Position: Q1 2026 in Review

Renaissance Technologies increased its Tenax Therapeutics (TENX) stake by 22% in Q1 2026, buying an estimated $366K and bringing the position to 152,600 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Renaissance Technologies first reported a position in TENX in Q3 2016 and has held it in 26 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Renaissance Technologies held 152,600 shares of Tenax Therapeutics worth $2.44M as of Q1 2026.
  • Renaissance Technologies bought 27,021 Tenax Therapeutics shares in Q1 2026, an estimated $366K.
  • Tenax Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1793 holding.
  • Renaissance Technologies first reported a position in Tenax Therapeutics in Q3 2016 and has held it in 26 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.